Ahmed Kamel – Egypt Daily News
Egypt has announced a major scientific breakthrough after researchers completed the country’s first large-scale genome sequencing project, uncovering millions of previously undocumented genetic variations that could reshape the future of healthcare in the country.
The Ministry of Health and Population said a national research team has published the first peer-reviewed study on the results of the Egypt Genome Project 1K (EGP1K), the largest-ever Egyptian initiative to sequence the full genomes of 1,024 unrelated citizens from 21 governorates.
The project represents a major step toward building a comprehensive genetic map of the Egyptian population, enabling more precise and personalized medical care.
Largest Egyptian Genetic Database Ever Built
According to the ministry spokesperson Hossam Abdelghaffar, the project was led by researcher Khaled Amer from the Egypt Center for Regenerative Medicine, in collaboration with Ahmed Mostafa.
More than 30 Egyptian scientists participated in the initiative under the “Egypt Genome Consortium,” with contributions from multiple academic and research institutions across the country.
51 Million Genetic Variants Identified
Researchers found more than 51 million genetic variations in total, including around 17 million variants that had never been recorded in any global genetic database before.
Scientists say this discovery provides the most detailed picture yet of the Egyptian genome and represents a major leap forward for population-based genetic research in the region.
Toward Precision Medicine in Egypt
Health officials said the findings could transform medical practice in Egypt by replacing reliance on foreign genetic databases with locally relevant data tailored to the Egyptian population.
The study highlights diseases that appear more frequently among Egyptians, including familial Mediterranean fever, thalassemia, and hereditary hearing loss, allowing for earlier detection and more targeted treatment strategies.
Concerns Over Foreign Risk Models
The research also found that genetic risk assessment tools developed in Europe may produce misleading results when applied to Egyptians.
According to the study, some models incorrectly classify a large proportion of Egyptians as high-risk for conditions such as stroke and chronic kidney disease, underscoring the need for Egypt-specific genetic reference data.
Public Health and Prevention Impact
The project estimates that about 9.1% of Egyptians carry the gene associated with familial Mediterranean fever, which could translate into thousands of cases annually.
Health experts say the data will help authorities design early screening programs, preventive care strategies, and more accurate genetic counseling for families at risk.
A Shift Toward Precision Healthcare
Officials described the project as a turning point in Egyptian medicine, moving the country toward “precision healthcare” tailored specifically to its population.
They emphasized that the initiative is not only a scientific milestone but also a long-term investment in improving healthcare efficiency, reducing costs, and enhancing treatment outcomes.
Egyptian health authorities said the national genome map will now serve as a key tool for doctors and researchers, marking a new era in personalized medicine across the country.
